Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia

This study has been completed.
Information provided by (Responsible Party):
Kjeld Schmiegelow, Rigshospitalet, Denmark Identifier:
First received: May 22, 2012
Last updated: September 4, 2012
Last verified: September 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)